Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

AURO-NINTEDANIB DIN 02526905

Status: Marketed
Holder: AURO PHARMA INC
Molecule: NINTEDANIB (NINTEDANIB ESILATE)

Health Canada record

Active ingredient(s)NINTEDANIB (NINTEDANIB ESILATE) 150 MG
Dosage formCapsule
RouteOral
SchedulePRESCRIPTION
ClassHuman
ATCL01EX09 NINTEDANIB
Original market date22-Dec-2025
Current status date22-Dec-2025
SourceHealth Canada DPD

Establishment licence of the holder

Auro Pharma Inc — licence 101305, currently licensed, last inspection rating C (2023-09-27).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing NINTEDANIB (NINTEDANIB ESILATE)

DINProductCompanyFormStrengthStatus
02526891AURO-NINTEDANIBAURO PHARMA INCCapsuleNINTEDANIB (NINTEDANIB ESILATE) 100 MGMarketed
02547511EUGIA-NINTEDANIBEUGIA PHARMA INC.CapsuleNINTEDANIB (NINTEDANIB ESILATE) 100 MGApproved
02547538EUGIA-NINTEDANIBEUGIA PHARMA INC.CapsuleNINTEDANIB (NINTEDANIB ESILATE) 150 MGApproved
02569248GLN-NINTEDANIBGLENMARK PHARMACEUTICALS CANADA INC.CapsuleNINTEDANIB (NINTEDANIB ESILATE) 150 MGApproved
02569221GLN-NINTEDANIBGLENMARK PHARMACEUTICALS CANADA INC.CapsuleNINTEDANIB (NINTEDANIB ESILATE) 100 MGApproved
02550849JAMP NINTEDANIBJAMP PHARMA CORPORATIONCapsuleNINTEDANIB (NINTEDANIB ESILATE) 100 MGMarketed
02540762JAMP NINTEDANIBJAMP PHARMA CORPORATIONCapsuleNINTEDANIB (NINTEDANIB ESILATE) 150 MGMarketed
02443074OFEVBOEHRINGER INGELHEIM (CANADA) LTD LTEECapsuleNINTEDANIB (NINTEDANIB ESILATE) 150 MGMarketed
02443066OFEVBOEHRINGER INGELHEIM (CANADA) LTD LTEECapsuleNINTEDANIB (NINTEDANIB ESILATE) 100 MGMarketed

Notices of Compliance

NOCDateSubmissionReason
312482023-07-19Abbreviated New Drug Submission (ANDS)
Request a quote for AURO-NINTEDANIB

How to read a Canadian DIN record